SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivimed Labs

BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 23, 16:00
104.00
-2.1 (-1.98%)
VOLUME 110,037
LIVE
NSE
Feb 23, 15:59
104.20
-1.8 (-1.7%)
VOLUME 324,966
Announcements on Vivimed Labs

20th-Feb-2017 12:06Source: BSE

Vivimed Labs- Limited Review Report for December 31, 2016

Vivimed Labs Ltd has informed BSE about :

1. Consolidated Limited Review for the period ended December 31, 2016

15th-Feb-2017 08:53Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding outcome of meeting of the Board of Directors of the Company held on February 14, 2017.

14th-Feb-2017 20:21Source: BSE

Vivimed Labs- Standalone & Consolidated Financial Results, Limited Review Report for December 31, 2016

Vivimed Labs Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Consolidated Financial Results for the period ended December 31, 2016...

7th-Feb-2017 18:06Source: BSE

Vivimed Labs- Notice of Postal Ballot

Vivimed Labs Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.

31st-Jan-2017 18:01Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sandeep Varalwar

30th-Jan-2017 14:21Source: BSE

Vivimed Labs- Board Meeting Intimation for Results & Closure of Trading Window

Vivimed Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider and approve the unaudited Financial Results of the ...

27th-Jan-2017 16:39Source: BSE

Vivimed Labs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011`

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Manohar Rao Varalwar

24th-Jan-2017 11:24Source: NSE

Vivimed Labs Limited

VIVIMEDLAB: The Exchange had sought clarification from Vivimed Labs Limited with respect to announcement dated 12-Jan-2017, regarding Outcome of Board Meeting held on January 12, 2017.On basis of abov...

19th-Jan-2017 12:47Source: BSE

Vivimed Labs- Shareholding for the Period Ended December 31, 2016

Vivimed Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly

19th-Jan-2017 11:27Source: BSE

Vivimed Labs- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016

Vivimed Labs Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing...

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.